MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Cathcart who wrote (140)	9/8/1997 9:32:00 AM
From: JOSEPH VON MEISTER	of 1826

I think that they have just lost interest after years of being misled by management. I also understand that Kopp has sold all his medical related issues and has moved into technology. Historically, this company has been a HUGE disappointment - however, I have checked Blitzer out and he is a top "CAN DO" guy. He will and is making things happen here - in my opinion. Also, we have never been closer to commercial success with Salagen, than we are now, due to the roll out of Salagen in Europe and Canada, and the likely Sjogren's approval in the US sometime soon. JVM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next